70831-55-9 Usage
Uses
Used in Pharmaceutical and Agrochemical Synthesis:
(2S)-N1,N1-dimethylpropane-1,2-diamine is used as a building block for the synthesis of various pharmaceuticals and agrochemicals due to its unique chemical structure and reactivity.
Used in Epoxy Resin Industry:
(2S)-N1,N1-dimethylpropane-1,2-diamine is used as a curing agent in epoxy resins, contributing to the hardening and setting of these resins for various applications.
Used in Organic Chemical Reactions:
(2S)-N1,N1-dimethylpropane-1,2-diamine is used as a catalyst in organic chemical reactions, facilitating and speeding up the processes.
Used in Polyurethane Foam Production:
(2S)-N1,N1-dimethylpropane-1,2-diamine is used in the production of polyurethane foam, a versatile material with applications in furniture, bedding, and insulation.
Used in Plastics Industry:
(2S)-N1,N1-dimethylpropane-1,2-diamine is also used in the production of certain types of plastics, enhancing their properties and performance.
Used in Material and Drug Development:
(2S)-N1,N1-dimethylpropane-1,2-diamine has potential applications in the development of new materials and drugs due to its unique chemical structure and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 70831-55-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,8,3 and 1 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 70831-55:
(7*7)+(6*0)+(5*8)+(4*3)+(3*1)+(2*5)+(1*5)=119
119 % 10 = 9
So 70831-55-9 is a valid CAS Registry Number.
70831-55-9Relevant academic research and scientific papers
SMALL MOLECULES THAT TARGET THE RNA THAT CAUSES ALS
-
Paragraph 00125; 00127, (2022/04/03)
Disclosed herein are compounds that selectively bind an expanded transcribed repeat r(G4C2)exp, prevent sequestration of RNA-binding proteins, and inhibit translation of repeat associated non-ATG (RAN) translation responsible for generation of toxic dipeptide repeats underlying diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The compounds and their pharmaceutical compositions are useful in treating a disease or condition characterized by an expanded G4C2 repeat RNA (r(G4C2)exp), such as ALS and FTD.
Structure of a Peptidal Antibiotic P168 produced by Paecilomyces lilacinus (Thom) Samson
Isogai, Akira,Suzuki, Akinori,Tamura, Saburo,Higashikawa, Shizuo,Kuyama, Shimpei
, p. 1405 - 1411 (2007/10/02)
The peptide antibiotic P168 contained a new amino acid, (2S,4S)-2-amino-6-hydroxy-4-methyl-8-oxodecanoic acid (6) and an amine, (S)-N1,N1-dimethylpropane-1,2-diamine (4) along with other unusual amino acids.The structure of the peptide was determined as (I) by in-beam mass spectrometry.
Structure of Leucinostatin A, New Peptide Antibiotic from Paecilomyces lilacinus A-267
Mori, Yuji,Tsuboi, Makoto,Suzuki, Makoto,Fukushima, Kazutaka,Arai, Tadashi
, p. 94 - 96 (2007/10/02)
A new antibiotic leucinostatin A was isolated from the culture filtrate of Paecilomyces lilacinus A-267 and its structure was elucidated by mass spectrometric and degradative methods.
